264 related articles for article (PubMed ID: 22074738)
1. BACE2 expression increases in human neurodegenerative disease.
Holler CJ; Webb RL; Laux AL; Beckett TL; Niedowicz DM; Ahmed RR; Liu Y; Simmons CR; Dowling AL; Spinelli A; Khurgel M; Estus S; Head E; Hersh LB; Murphy MP
Am J Pathol; 2012 Jan; 180(1):337-50. PubMed ID: 22074738
[TBL] [Abstract][Full Text] [Related]
2. BACE1 and BACE2 enzymatic activities in Alzheimer's disease.
Ahmed RR; Holler CJ; Webb RL; Li F; Beckett TL; Murphy MP
J Neurochem; 2010 Feb; 112(4):1045-53. PubMed ID: 19968762
[TBL] [Abstract][Full Text] [Related]
3. Distinct transcriptional regulation and function of the human BACE2 and BACE1 genes.
Sun X; Wang Y; Qing H; Christensen MA; Liu Y; Zhou W; Tong Y; Xiao C; Huang Y; Zhang S; Liu X; Song W
FASEB J; 2005 May; 19(7):739-49. PubMed ID: 15857888
[TBL] [Abstract][Full Text] [Related]
4. The proteins BACE1 and BACE2 and beta-secretase activity in normal and Alzheimer's disease brain.
Stockley JH; O'Neill C
Biochem Soc Trans; 2007 Jun; 35(Pt 3):574-6. PubMed ID: 17511655
[TBL] [Abstract][Full Text] [Related]
5. BACE2, as a novel APP theta-secretase, is not responsible for the pathogenesis of Alzheimer's disease in Down syndrome.
Sun X; He G; Song W
FASEB J; 2006 Jul; 20(9):1369-76. PubMed ID: 16816112
[TBL] [Abstract][Full Text] [Related]
6. Beta-secretase cleavage at amino acid residue 34 in the amyloid beta peptide is dependent upon gamma-secretase activity.
Shi XP; Tugusheva K; Bruce JE; Lucka A; Wu GX; Chen-Dodson E; Price E; Li Y; Xu M; Huang Q; Sardana MK; Hazuda DJ
J Biol Chem; 2003 Jun; 278(23):21286-94. PubMed ID: 12665519
[TBL] [Abstract][Full Text] [Related]
7. BACE2: A Promising Neuroprotective Candidate for Alzheimer's Disease.
Yeap YJ; Kandiah N; Nizetic D; Lim KL
J Alzheimers Dis; 2023; 94(s1):S159-S171. PubMed ID: 36463454
[TBL] [Abstract][Full Text] [Related]
8. The beta-secretase, BACE: a prime drug target for Alzheimer's disease.
Vassar R
J Mol Neurosci; 2001 Oct; 17(2):157-70. PubMed ID: 11816789
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice.
Shimshek DR; Jacobson LH; Kolly C; Zamurovic N; Balavenkatraman KK; Morawiec L; Kreutzer R; Schelle J; Jucker M; Bertschi B; Theil D; Heier A; Bigot K; Beltz K; Machauer R; Brzak I; Perrot L; Neumann U
Sci Rep; 2016 Feb; 6():21917. PubMed ID: 26912421
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of insoluble amyloid-β in down's syndrome is associated with increased BACE-1 and neprilysin activities.
Miners JS; Morris S; Love S; Kehoe PG
J Alzheimers Dis; 2011; 23(1):101-8. PubMed ID: 20930275
[TBL] [Abstract][Full Text] [Related]
11. Beta-amyloid secretases and beta-amloid degrading enzyme expression in lens.
Li G; Percontino L; Sun Q; Qazi AS; Frederikse PH
Mol Vis; 2003 May; 9():179-83. PubMed ID: 12740567
[TBL] [Abstract][Full Text] [Related]
12. BACE2 degradation mediated by the macroautophagy-lysosome pathway.
Liu X; Wang Z; Wu Y; Wang J; Song W
Eur J Neurosci; 2013 Jun; 37(12):1970-7. PubMed ID: 23773066
[TBL] [Abstract][Full Text] [Related]
13. RCAN1 Inhibits BACE2 Turnover by Attenuating Proteasome-Mediated BACE2 Degradation.
Qiu K; Wang S; Wang X; Wang F; Wu Y
Biomed Res Int; 2020; 2020():1920789. PubMed ID: 32566665
[TBL] [Abstract][Full Text] [Related]
14. BACE1: the beta-secretase enzyme in Alzheimer's disease.
Vassar R
J Mol Neurosci; 2004; 23(1-2):105-14. PubMed ID: 15126696
[TBL] [Abstract][Full Text] [Related]
15. BACE2 degradation is mediated by both the proteasome and lysosome pathways.
Qiu K; Liang W; Wang S; Kong T; Wang X; Li C; Wang Z; Wu Y
BMC Mol Cell Biol; 2020 Mar; 21(1):13. PubMed ID: 32160867
[TBL] [Abstract][Full Text] [Related]
16. A combination Alzheimer's therapy targeting BACE1 and neprilysin in 5XFAD transgenic mice.
Devi L; Ohno M
Mol Brain; 2015 Mar; 8():19. PubMed ID: 25884928
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Synaptic Amyloid-β Generation through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease.
Ye X; Feng T; Tammineni P; Chang Q; Jeong YY; Margolis DJ; Cai H; Kusnecov A; Cai Q
J Neurosci; 2017 Mar; 37(10):2639-2655. PubMed ID: 28159908
[TBL] [Abstract][Full Text] [Related]
18. Altered beta-secretase enzyme kinetics and levels of both BACE1 and BACE2 in the Alzheimer's disease brain.
Stockley JH; Ravid R; O'Neill C
FEBS Lett; 2006 Dec; 580(28-29):6550-60. PubMed ID: 17113083
[TBL] [Abstract][Full Text] [Related]
19. Beta-secretase (BACE) as a drug target for Alzheimer's disease.
Vassar R
Adv Drug Deliv Rev; 2002 Dec; 54(12):1589-602. PubMed ID: 12453676
[TBL] [Abstract][Full Text] [Related]
20. Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients.
Li R; Lindholm K; Yang LB; Yue X; Citron M; Yan R; Beach T; Sue L; Sabbagh M; Cai H; Wong P; Price D; Shen Y
Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3632-7. PubMed ID: 14978286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
